26th Annual Meeting and Education Day of the Society for Neuro-Oncology November 18 - 21, 2021
https://www.eventscribe.net/2021/SNO/aaStatic.asp?SFP=S0tBV0JIR1JANzU2OUBKb2luIFNOTy9BYm91dCBCb3N0b24
IMO, 100% chance of final data from paxalisib phase2 Kazia / Danna-Farber GBM trial results.
I noticed Dr Priscilla Brastianos signed the SNO invitation letter.
Add to My Watchlist
What is My Watchlist?